Dyne Therapeutics (DYN)
Develops targeted genetic medicines for neuromuscular diseases through its FORCE delivery platform.
$16.54
vs last close−0.60 (−3.50%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.88
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Nov '25Mar '26May '26Jul '26Nov '26
Reported−$0.88−$1.05−$0.97−$0.76−$0.76−$0.73−$1.08Pending
Estimate−$0.92−$0.88−$0.99−$0.81−$0.74−$0.77−$0.75−$0.88
Surprise+4.3%−19.3%+2.0%+6.2%−2.7%+5.5%−44.2%—
RevenueReportedEstimate
Feb '25May '25Jul '25Nov '25Mar '26May '26Jul '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.82 | — | — |
| Sep 2027 | −$0.85 | — | — |
| Jun 2027 | −$0.86 | — | — |
| Mar 2027 | −$0.88 | — | — |
| Dec 2026 | −$0.90 | — | — |
| Nov 2026 | −$0.88 | — | — |
| Jul 2026 | −$0.75 | −$1.08 | −44.2% |
| May 2026 | −$0.77 | −$0.73 | +5.5% |
| Mar 2026 | −$0.74 | −$0.76 | −2.7% |
| Nov 2025 | −$0.81 | −$0.76 | +6.2% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Sep 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 | |||
| Feb 2015 | |||
| Nov 2014 | |||
| Aug 2014 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.82 | — | — | $16.9M | — | — | — |
| Sep 2027 | −$0.85 | — | — | $12.3M | — | — | — |
| Jun 2027 | −$0.86 | — | — | $7.6M | — | — | — |
| Mar 2027 | −$0.88 | — | — | $3.0M | — | — | — |
| Dec 2026 | −$0.90 | — | — | $0 | — | — | — |
| Nov 4, 2026 | −$0.88 | — | — | $0 | — | — | — |
| Jul 30, 2026 | −$0.75 | −$1.08 | −44.2% | — | — | — | −2.1% |
| May 11, 2026 | −$0.77 | −$0.73 | +5.5% | — | — | — | +4.8% |
| Mar 2, 2026 | −$0.74 | −$0.76 | −2.7% | — | — | — | +3.4% |
| Nov 5, 2025 | −$0.81 | −$0.76 | +6.2% | — | — | — | −2.9% |
| Jul 28, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 2, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Oct 30, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 2, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Sep 17, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Feb 22, 2018 | |||||||
| Nov 1, 2017 | |||||||
| Aug 4, 2017 | |||||||
| May 5, 2017 | |||||||
| Feb 24, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 4, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 7, 2015 | |||||||
| May 7, 2015 | |||||||
| Feb 25, 2015 | |||||||
| Nov 6, 2014 | |||||||
| Aug 7, 2014 |